Loading your page…

Pharmaceutical group

KARO

34 medicines7 countries

A group of 5 companies with 34 medicines in 7 countries.

Its medicines

Group structure

5 companies in 3 countries

Sweden3

Canada1

Karo Enrg les CosmetiquesAuthorisation holder

United States1

Karo HlthcareAuthorisation holder · 5 medicines

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 34

Medicine	Substance	Country	Status	Authorised
BURINEX1 mg · Tablet	Bumetanide	Canada	Marketed	1993
BURINEX5 mg · Tablet	Bumetanide	Canada	Marketed	1993
Burinex 0,5 mg/ml, oplossing voor injectieOplossing voor injectie	Bumetanide	Netherlands	Authorised	1988
Burinex 1 mg, tablettenTablet	Bumetanide	Netherlands	Authorised	1976
Burinex 2 mg, tablettenTablet	Bumetanide	Netherlands	Authorised	1995
Burinex 5 mg, tablettenTablet	Bumetanide	Netherlands	Authorised	1981
CONDYLINESoluzione cutanea	Podophyllotoxin	Italy	Authorised
Condyline 0,5%, applicatievloeistof 5 mg/mlVloeistof voor cutaan gebruik	Podophyllotoxin	Netherlands	Authorised	1987
FORDIURAN 1 mg COMPRIMIDOS1 mg · Comprimido	Bumetanide	Spain	Marketed	1973
LAMISIL1% · GEL	Terbinafine	United States	Not marketed	1998
LAMISIL1% · Solution	Terbinafine	United States	Not marketed	1997
Lamisil 10 mg/g kremakrema	Terbinafine	Croatia	Marketed	2024
LAMISIL AT1% · GEL	Terbinafine	United States	Marketed	2006
LAMISIL AT1% · Solution	Terbinafine	United States	Marketed	2000
LAMISIL AT1% · Spray	Terbinafine	United States	Marketed	2000
Lamisil DermGel 1%, gelGel	Terbinafine	Netherlands	Authorised	2000
Lamisil DermGel 10 mg/g gelgel	Terbinafine	Croatia	Not marketed	2024
Lamisil huidschimmelcrème 10 mg/g, hydrofiele crèmeCrème	Terbinafine	Netherlands	Authorised	1991
Lamisil Lotion 1%, oplossing voor cutaan gebruikOplossing voor cutaan gebruik	Terbinafine	Netherlands	Authorised	1998
Lamisil once 1%, oplossing voor cutaan gebruik 10 mg/gOplossing voor cutaan gebruik	Terbinafine	Netherlands	Authorised	2006
Lamisil Once 10 mg/g otopina za kožuotopina za kožu	Terbinafine	Croatia	Authorised	2024
Lamisil Spray 1%, huidspray, oplossingHuidspray, oplossing	Terbinafine	Netherlands	Authorised	1998
Lamisil voetschimmelcrème 10 mg/g, hydrofiele crèmeCrème	Terbinafine	Netherlands	Authorised	2013
PEVARYLOvulo	Econazole	Italy	Authorised
PEVISONEEmulsione cutanea	Econazole, Triamcinolone	Italy	Authorised

Sources and licences

Country	Medicines	Current	Past	Companies
Netherlands	12	12	0	Companies All medicines
Italy	6	6	0	Companies All medicines
United States	5	5	0	Companies All medicines
Canada	4	4	0	Companies All medicines
Spain	3	3	0	Companies All medicines
Croatia	3	3	0	Companies All medicines
Romania	1	0	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 13 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removalCorrections from the company itself are welcome.

KARO

Group structure

Sweden3

Canada1

United States1

Medicines

Know your medicines, with the sources.

KARO

Group structure

Sweden3

Canada1

United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇸🇪Sweden3

🇨🇦Canada1

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Group structure

🇸🇪Sweden3

🇨🇦Canada1

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Sweden3

Canada1

United States1

Sweden3

Canada1

United States1